SGLT-2 inhibitors reduce mortality risk in HF with reduced EF but not in HF with preserved EF Medical Dialogues Editorial Team6 May 2022 8:45 AM ISTChina: In a new study published in Diabetes Research and Clinical Practice it was seen that in individuals with heart failure (HF) with reduced...
Adjuvant Therapy with Dapagliflozin bests Insulin Dose Escalation in Diabetes: Study MD Bureau15 Jun 2021 9:00 AM ISTNearly 1 in 4 patients with type 2 diabetes mellitus eventually require insulin therapy because of progressive deterioration of glycemic control. A...
Health Minister discusses side-effects of SGLT-2 inhibitors in the parliament Meghna A Singhania8 Feb 2021 4:10 PM ISTNew Delhi: With the rising incidence of diabetes in the country, SGLT-2 inhibitors have emerged as one of the preferred modality of treatment....
Sotagliflozacin lowers death risk and hospitalization in diabetes with HF: NEJM Dr. Kamal Kant Kohli25 Nov 2020 12:30 PM ISTAccording to the result of the trial was published in The NEW ENGLAND JOURNAL of MEDICINE on November 16, 2020 Sotagliflozin lowers total number of...
